Skip to main content
Log in

Servier, generic companies fined for pay-for-delay deals

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. where generic companies receive payments for delaying the launch of generic versions of branded drugs

Reference

  • European Union. Decision in Servier case. Media Release : 9 Jul 2014. Available from: URL: http://europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Servier, generic companies fined for pay-for-delay deals. PharmacoEcon Outcomes News 707, 10 (2014). https://doi.org/10.1007/s40274-014-1405-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1405-y

Navigation